Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (28)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Epstein, S. L.
Right arrow Articles by Subbarao, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Epstein, S. L.
Right arrow Articles by Subbarao, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Immunology, Vol. 12, No. 1, 91-101, January 2000
© 2000 Japanese Society for Immunology

Vaccination with DNA encoding internal proteins of influenza virus does not require CD8+ cytotoxic T lymphocytes: either CD4+ or CD8+ T cells can promote survival and recovery after challenge

Suzanne L. Epstein, Abigail Stack4, Julia A. Misplon, Chia-Yun Lo, Howard Mostowski, Jack Bennink1 and Kanta Subbarao2

Molecular Immunology Laboratory, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, HFM-521, Building 29B, Room 2G15, 29 Lincoln Drive, Bethesda, MD 20892-4555, USA
1 Laboratory of Viral Diseases, Viral Immunology Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Building 4, Room 205, 9000 Rockville Pike, Bethesda, MD 20892, USA
2 Influenza Branch, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, GA 30333, USA

Correspondence to: S. L. Epstein

DNA vaccination offers the advantages of viral gene expression within host cells without the risks of infectious virus. Like viral vaccines, DNA vaccines encoding internal influenza virus proteins can induce immunity to conserved epitopes and so may defend the host against a broad range of viral variants. CD8+ cytotoxic T lymphocytes (CTL) have been described as essential effectors in protection by influenza nucleoprotein (NP), although a lesser role of CD4+ cells has been reported. We immunized mice with plasmids encoding influenza virus NP and matrix (M). NP + M DNA allowed B6 mice to survive otherwise lethal challenge infection, but did not protect B6-ß2m(–/–) mice defective in CD8+ CTL. However, this does not prove CTL are required, because ß2m(–/–) mice have multiple immune abnormalities. We used acute T cell depletion in vivo to identify effectors critical for defense against challenge infection. Since lung lymphocytes are relevant to virus clearance, surface phenotypes and cytolytic activity of lung lymphocytes were analyzed in depleted animals, along with lethal challenge studies. Depletion of either CD4+ or CD8+ T cells in NP + M DNA-immunized BALB/c mice during the challenge period did not significantly decrease survival, while simultaneous depletion of CD4+ and CD8+ cells or depletion of all CD90+ cells completely abrogated survival. We conclude that T cell immunity induced by NP + M DNA vaccination is responsible for immune defense, but CD8+ T cells are not essential in the active response to this vaccination. Either CD4+ or CD8+ T cells can promote survival and recovery in the absence of the other subset.

Keywords: infectious immunity-virus, influenza, T lymphocytes, lung, transgenic/knockout

4 Present address: National Research Council, National Academy of Sciences, Washington, DC 20418, USA

Transmitting editor: J. Berzofsky


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Virol.Home page
L. A. Perrone, A. Ahmad, V. Veguilla, X. Lu, G. Smith, J. M. Katz, P. Pushko, and T. M. Tumpey
Intranasal Vaccination with 1918 Influenza Virus-Like Particles Protects Mice and Ferrets from Lethal 1918 and H5N1 Influenza Virus Challenge
J. Virol., June 1, 2009; 83(11): 5726 - 5734.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. M. Carragher, D. A. Kaminski, A. Moquin, L. Hartson, and T. D. Randall
A Novel Role for Non-Neutralizing Antibodies against Nucleoprotein in Facilitating Resistance to Influenza Virus
J. Immunol., September 15, 2008; 181(6): 4168 - 4176.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. M. Brown, A. M. Dilzer, D. L. Meents, and S. L. Swain
CD4 T cell-mediated protection from lethal influenza: perforin and antibody-mediated mechanisms give a one-two punch.
J. Immunol., September 1, 2006; 177(5): 2888 - 2898.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. E. Applequist, E. Rollman, M. D. Wareing, M. Liden, B. Rozell, J. Hinkula, and H.-G. Ljunggren
Activation of Innate Immunity, Inflammation, and Potentiation of DNA Vaccination through Mammalian Expression of the TLR5 Agonist Flagellin
J. Immunol., September 15, 2005; 175(6): 3882 - 3891.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
I. M. Belyakov, P. Earl, A. Dzutsev, V. A. Kuznetsov, M. Lemon, L. S. Wyatt, J. T. Snyder, J. D. Ahlers, G. Franchini, B. Moss, et al.
Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses
PNAS, August 5, 2003; 100(16): 9458 - 9463.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
P. P. Heinen, F. A. Rijsewijk, E. A. de Boer-Luijtze, and A. T. J. Bianchi
Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus
J. Gen. Virol., August 1, 2002; 83(8): 1851 - 1859.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
P. P. Heinen, E. A. de Boer-Luijtze, and A. T. J. Bianchi
Respiratory and systemic humoral and cellular immune responses of pigs to a heterosubtypic influenza A virus infection
J. Gen. Virol., November 1, 2001; 82(11): 2697 - 2707.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. E. Crowe Jr., C.-Y. Firestone, and B. R. Murphy
Passively Acquired Antibodies Suppress Humoral But Not Cell-Mediated Immunity in Mice Immunized with Live Attenuated Respiratory Syncytial Virus Vaccines
J. Immunol., October 1, 2001; 167(7): 3910 - 3918.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. A. Benton, J. A. Misplon, C.-Y. Lo, R. R. Brutkiewicz, S. A. Prasad, and S. L. Epstein
Heterosubtypic Immunity to Influenza A Virus in Mice Lacking IgA, All Ig, NKT Cells, or {{gamma}}{{delta}} T Cells
J. Immunol., June 15, 2001; 166(12): 7437 - 7445.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. M. Tumpey, M. Renshaw, J. D. Clements, and J. M. Katz
Mucosal Delivery of Inactivated Influenza Vaccine Induces B-Cell-Dependent Heterosubtypic Cross-Protection against Lethal Influenza A H5N1 Virus Infection
J. Virol., June 1, 2001; 75(11): 5141 - 5150.
[Abstract] [Full Text]


Home page
J. Gen. Virol.Home page
E. O’Neill, S. L. Krauss, J. M. Riberdy, R. G. Webster, and D. L. Woodland
Heterologous protection against lethal A/HongKong/156/97 (H5N1) influenza virus infection in C57BL/6 mice
J. Gen. Virol., November 1, 2000; 81(11): 2689 - 2696.
[Abstract] [Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.